The Shotlee Journal
Browse Shotlee articles about Mounjaro.
Showing 9 / 799 Mounjaro articles
As millions use GLP-1 medications like Ozempic for weight loss, clinicians are seeing a rise in new eating disorders dubbed 'agonorexia.' These drugs' powerful appetite suppression may drive dangerous food and body image obsessions, even in those without prior history. Experts warn current screening may miss at-risk patients.
Shares in Novo Nordisk, maker of Ozempic and Wegovy, plunged 18% after a sales warning flagged up to 13% decline in the US market due to falling GLP-1 drug prices. Despite 2025 sales growth of 6% to 309 billion kronor, the stock wipeout erased $32 billion in value. CEO Mike Doustdar highlights the upcoming Wegovy pill as a key future driver.
New Zealand's Pharmac advisory panel has recommended funding Wegovy for chronic weight management in those with high BMI and related conditions. Paediatric endocrinologist Professor Wayne Cutfield argues strongly for including obese teens to prevent lifelong health crises. This guide breaks down the science, evidence, and implications.
When 7-year-old Jessa injected her mom's Ozempic thinking it was stomach medicine, she faced severe vomiting, dehydration, and kidney risks. This incident underscores the dangers of GLP-1 medications like semaglutide and tirzepatide in children. Discover prevention tips and what to do in an emergency.
GLP-1 medications like Ozempic and Wegovy are transforming weight management, but older adults face heightened risks like muscle loss and fractures. This guide breaks down the science-backed concerns, monitoring strategies, and when to avoid them. Stay informed to make safer health choices.
When Bollywood star Tamanna Bhatia appeared slimmer, social media buzzed with Ozempic accusations, sparking debates on beauty standards and rapid weight loss. Beyond the rumors, Ozempic (semaglutide) is a powerful GLP-1 drug transforming weight management. This guide dives into the science, risks, and healthier paths forward.
GLP-1 drugs are revolutionizing weight loss, but workplace access risks creating inequities. This guide explores the clinical science behind Ozempic, Wegovy, Mounjaro, and Zepbound, plus employer strategies for inclusive well-being. Pair meds with nutrition and support for lasting results.
Women on GLP-1 drugs like tirzepatide and semaglutide are reporting surprise pregnancies after significant weight loss. This guide explains the mechanisms, emerging trends, and essential precautions for those on these medications considering family planning.
Jelly Roll transformed from 550 lbs to 265 lbs through disciplined lifestyle changes, avoiding GLP-1 drugs like Ozempic due to vocal health concerns. His story highlights high-protein eating, consistent movement, and overcoming food addiction. Discover actionable strategies backed by science for your own metabolic health journey.
